OCS Competitors & Alternatives

Compare Oculis Holding AG Ordinary shares with similar stocks in the same industry

Biotechnology

OCS

Main Stock
$11.72
Tradestie Score
57
Market Cap
$910.64M
Revenue Growth
-0.3%
Analyst Upside
+219.2%

Top Competitors

228 stocks in Biotechnology
Company Price Market Cap P/E Score Action
AVBP ArriVent BioPharma, Inc. Common Stock
$33.74
$748.90M - 58 Compare
TBPH Theravance Biopharma, Inc.
$16.97
$726.21M 7.4 63 Compare
NRIX Nurix Therapeutics, Inc. Common stock
$18.86
$718.62M - 62 Compare
TYRA Tyra Biosciences, Inc. Common Stock
$30.06
$715.25M - 55 Compare
DAWN Day One Biopharmaceuticals, Inc. Common Stock
$21.53
$704.73M - 59 Compare
PVLA Palvella Therapeutics, Inc. Common Stock
$118.68
$699.30M - 59 Compare
GYRE Gyre Therapeutics, Inc. Common Stock
$6.13
$688.47M - 55 Compare
TERN Terns Pharmaceuticals, Inc. Common Stock
$52.95
$683.46M - 57 Compare
ANL ANL
$10.60
$669.74M - 53 Compare
MGTX MeiraGTx Holdings plc Ordinary Shares
$11.81
$665.30M - 57 Compare

Data updated: Jun 23, 2026 | Industry: Biotechnology (SIC 2834)

228 stocks in this industry